Literature DB >> 16772116

Molecular cytogenetic evaluation of 10 uveal melanoma cell lines.

Jason S White1, Robert L Becker, Ian W McLean, Alison E Director-Myska, Joginder Nath.   

Abstract

Uveal melanoma is the most common intraocular tumor in adults and often results in unilateral blindness and/or death. Previous cytogenetic characterizations of this tumor consistently revealed chromosomal abnormalities involving chromosomes 3, 6, and 8; reports of other abnormalities vary in frequency. We defined cytogenetic abnormalities of this tumor using complementary in situ hybridization techniques on 10 uveal melanoma cell lines. Synthesis of comparative genomic hybridization (CGH) and spectral karyotyping (SKY) results revealed that chromosomal rearrangement is involved in DNA sequence copy number abnormalities throughout the genome, but monosomy 3 was not found. Monosomy 3 is thought to be a significant prognostic indicator, so its absence was investigated further. Fluorescence in situ hybridization (FISH) for chromosome 3 revealed approximately 1 centromere signal per cell, but probes for 3p and 3q revealed multiple telomere signals per cell, suggesting chromosomal rearrangement without whole-chromosome loss. Based on combined CGH, SKY, and FISH data, we propose that chromosome 3 is more frequently involved in chromosomal rearrangements than whole-chromosome loss in uveal melanoma. Future approaches should be designed to confirm and enhance the resolution of regions of imbalance in primary tumors. Once identified, conserved chromosomal alterations that contribute to uveal melanoma may reveal the underlying aspects of uveal melanoma onset, metastasis and resistance to current treatment modalities.

Entities:  

Mesh:

Year:  2006        PMID: 16772116     DOI: 10.1016/j.cancergencyto.2005.11.016

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  10 in total

1.  Microtubule breakage is not a major mechanism for resolving end-to-end chromosome fusions generated by telomere dysfunction during the early process of immortalization.

Authors:  W Deng; S W Tsao; X-Y Guan; A L M Cheung
Journal:  Chromosoma       Date:  2007-08-28       Impact factor: 4.316

2.  Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.

Authors:  Joseph C Manarang; Deborah C Otteson; Alison M McDermott
Journal:  Curr Eye Res       Date:  2017-09-14       Impact factor: 2.424

3.  Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array.

Authors:  Arun D Singh; Mary E Aronow; Yang Sun; Gurkan Bebek; Yogen Saunthararajah; Lynn R Schoenfield; Charles V Biscotti; Raymond R Tubbs; Pierre L Triozzi; Charis Eng
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-05       Impact factor: 4.799

Review 4.  Choroidal biopsies; a review and optimised approach.

Authors:  R N Hussain; B Damato; H Heimann
Journal:  Eye (Lond)       Date:  2022-08-08       Impact factor: 4.456

Review 5.  Molecular pathology of uveal melanoma.

Authors:  S E Coupland; S L Lake; M Zeschnigk; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

6.  FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas.

Authors:  Laura Bonaldi; Edoardo Midena; Barbara Filippi; Elisabetta Tebaldi; Raffaella Marcato; Raffaele Parrozzani; Alberto Amadori
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-02       Impact factor: 4.553

Review 7.  Uveal melanoma: From diagnosis to treatment and the science in between.

Authors:  Chandrani Chattopadhyay; Dae Won Kim; Dan S Gombos; Junna Oba; Yong Qin; Michelle D Williams; Bita Esmaeli; Elizabeth A Grimm; Jennifer A Wargo; Scott E Woodman; Sapna P Patel
Journal:  Cancer       Date:  2016-03-15       Impact factor: 6.860

Review 8.  Authenticating cell lines in ophthalmic research laboratories.

Authors:  Robert Folberg; Shrihari S Kadkol; Shahar Frenkel; Klara Valyi-Nagy; Martine J Jager; Jacob Pe'er; Andrew J Maniotis
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-08       Impact factor: 4.799

9.  Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.

Authors:  Mark J de Lange; Sake I van Pelt; Mieke Versluis; Ekaterina S Jordanova; Wilma G M Kroes; Claudia Ruivenkamp; Sjoerd H van der Burg; Grégorius P M Luyten; Thorbald van Hall; Martine J Jager; Pieter A van der Velden
Journal:  Oncotarget       Date:  2015-11-10

10.  Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.

Authors:  Eva Sipos; Nikoletta Dobos; David Rozsa; Klara Fodor; Gabor Olah; Zsuzsanna Szabo; Lorant Szekvolgyi; Andrew V Schally; Gabor Halmos
Journal:  Onco Targets Ther       Date:  2018-02-22       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.